Additional European Equity News

Bayer (BAYN GY) - Bayer initiates phase III study with finerenone in adults with chronic kidney disease and type 1 diabetes. (Newswires) 

Casino (CO FP) - Commences sale of remaining 11.7% stake in Assai to strengthen its liquidity (Newswires)

DS Smith (SMDS LN) - FY22/23 (GBP): Adj Op. 861mln (prev. 616mln), Revenue 8.22bln (prev. 7.24bln). (Newswires) 

GSK (GSK LN) - US centers for Disease Control and Prevention's Advisory Committee on Immunisation Practices votes to recommend Arexvy for the prevention of RSV disease in adults aged 60 and older, with shared clinical decision making. (Newswires)

SBB (SBBB SS) - Sweden's FSA says they will investigate whether SBB broke accounting rules in 2021 annual report. (Newswires)

SES Imagotag (SESL FP) - Gotham City Research releases a short report on Co. says "We believe SESL financial statements are materially misleading, incorrect, and deficient. An independent & comprehensive investigation would confirm our opinions.", says Chinese listed BOE is the largest shareholder, largest supplier, one of the largest customers, JV partner, and on the audit committee. Potential for financial malfeasance is high. (SES Imagotag )

Whitbread (WTB LN) - In Q1 trading update says revenue +19% y/y and trading momentum is strong. We remain positive about the full year outlook. Forward booked revenue in UK is well ahead of last year and in Germany we remain on course to reach break-even on a run-rate basis during 2024. (Newswires)

Anheuser-Busch Inbev (ABI GY) upgraded to Buy from Hold at Deutsche Bank

Valmet Corp (VALMT FH) downgraded to Hold from Buy at Danske Bank

ISS A/S (ISS DC) upgraded to Buy from Neutral at UBS

Whitbread (WTB LN) reiterated with Overweight at JP Morgan Chase

22 Jun 2023 - 07:20- EquitiesResearch Sheet- Source: Newsquawk